First Psychiatry Consortium funded project announced for schizophreniaA partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Share XFirst Psychiatry Consortium funded project announced for schizophreniahttps://pharmaphorum.com/partner-content/first-psychiatry-consortium-funded-project-announced-for-schizophrenia/
The state of UK drug discovery: the pharmaphorum podcastThe UK environment for drug discovery, the impact of artificial intelligence (AI) on medicines research and the role Share XThe state of UK drug discovery: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/medicines-discovery-catapult-uk-drug-discovery/
On-demand AI platform gets Innovate UK fundingChief.AI and Medicines Discovery Catapult have been awarded £370,000 of funding from Innovate UK to develop a searchable Share XOn-demand AI platform gets Innovate UK fundinghttps://pharmaphorum.com/news/on-demand-ai-platform-gets-innovate-uk-funding/
